Table 1.

Country-specific regulations and guidelines regarding the settings where intravitreal anti-VEGFs can be administered

Country	Continent	Intravitreal setting			Intravitreal anti-VEGF injection allowed outside hospital?
		Operating theatre	Ambulatory surgery room/Clean room	Office
Australia	Australia/Oceania	YES	YES	YES	YES
Belgium	Europe	YES	YES	NO	YES
Brazil	South America	YES	YES	YES	YES
Canada	North America	YES	YES	YES	YES
Colombia	South America	YES	YES	NO	YES
Finland	Europe	YES	YES	NO	YES
France	Europe	YES	YES	YES	YES
Germany	Europe	YES	YES	NO	YES
India	Asia	YES	YES	YES	YES
Ireland	Europe	YES	YES	NO	YES
Italy	Europe	YES	YES	NO	NO (*)
Japan	Asia	YES	YES	YES	YES
Mexico	North America	YES	YES	YES	YES
Netherlands	Europe	YES	YES	NO	YES
New Zealand	Australia/Oceania	YES	YES	YES	YES
Norway	Europe	YES	YES	NO	YES
Poland	Europe	YES	YES	NO	YES
Portugal	Europe	YES	YES	NO	YES
Slovenia	Europe	YES	YES	NO	YES
Spain	Europe	YES	YES	NO	YES
Switzerland	Europe	YES	YES	NO	YES
United Kingdom	Europe	YES	YES	NO	YES
United States	North America	YES	YES	YES	YES

Legend: (*) Intravitreal anti-VEGFs are allowed only in hospital settings (or analogous healthcare facilities); VEGF: vascular endothelial growth factor